ancient wisdom · Remedy
Xuezhikang Capsule; Xue Zhi Kang Capsule
Xuezhikang Capsule; Xue Zhi Kang Capsule. Chinese patent medicines. For: Used for hyperlipidemia caused by phlegm and blood stasis, symptoms such as shortness of breath, fatigue, dizziness, headache, chest tightness, abdominal distension, lack of appetite and appetite
📜 Names
Pinyin Name
Xuezhikang Jiaonang
中文名 (Chinese)
血脂康胶囊
English Name
Xuezhikang Capsule; Xue Zhi Kang Capsule
💊 Form & Use
Category
Chinese patent medicines
Dosage Form
胶囊剂 (Capsule)
Administration
Oral
Source / 出处
Chinese Pharmacopoeia 2020 edition
🩺 Syndromes & Indications
Syndromes (中文)
化浊降脂，活血化瘀，健脾消食
Indications (中文)
用于痰阻血瘀所致的高脂血症，症见气短、乏力、头晕、头痛、胸闷、腹胀、食少纳呆；也可用于高脂血症及动脉粥样硬化所致的其他的心脑血管疾病的辅助治疗
Indications (English)
Used for hyperlipidemia caused by phlegm and blood stasis, symptoms such as shortness of breath, fatigue, dizziness, headache, chest tightness, abdominal distension, lack of appetite and appetite; it can also be used for hyperlipidemia and other heart caused by atherosclerosis Adjuvant treatment of cerebrovascular diseases
1
Clinical Trials
3
Meta-Analyses
2
PubMed References
Top Conditions Studied with Xuezhikang Capsule; Xue Zhi Kang Capsule
📋 Sample Trials
NCT02057302
A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia
Completed · Phase 4 · Dyslipidemia
📊 Sample Meta-Analyses
CRD42017062739
Chinese patent medicine for hyperlipidemias: a network meta-analysis of randomized controlled trials
Hyperlipidemias, including hypercholesterolemia, hyperlipoproteinemias, hypertri
CRD42017062486
Lipid-lowering effect of Xuezhikang capsule for patients with coronary heart disease combined with hyperlipidemia: protocol for a systematic review
Dyslipidemia is a risk for cardiovascular disease. Statins can cut down the leve
CRD42019132518
Xuezhikang capsule for hypercholesterolaemia: a systematic review and meta-analysis of randomized clinical trials
Hypercholesterolemia is a condition characterized by high levels of cholesterol
📚 Sample References
PMID 29921884
Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules
Acta Pharmacol Sin · 2018
PMID 36126782
The effect of Xuezhikang capsule on gene expression profile in brown adipose tissue of obese spontaneously hypertensive rats
J Ethnopharmacol · 2023
🏥 Indications — click any to find related diseases
🏥 Linked Health Topics 1 · matched via study conditions